Ryanodine receptor phosphorylation by oxidized CaMKII contributes to the cardiotoxic effects of cardiac glycosides. - Wikidata - awgldk - TriplyDB

Ryanodine receptor phosphorylation by oxidized CaMKII contributes to the cardiotoxic effects of cardiac glycosides.

Ryanodine receptor phosphorylation by oxidized CaMKII contributes to the cardiotoxic effects of cardiac glycosides.

http://www.wikidata.org/entity/Q37404177

about

Abnormal Ca(2+) cycling in failing ventricular myocytes: role of NOS1-mediated nitroso-redox balance Obligatory role of neuronal nitric oxide synthase in the heart's antioxidant adaptation with exercise Protein methionine oxidation augments reperfusion injury in acute ischemic stroke CaMKII-dependent responses to ischemia and reperfusion challenges in the heart.Toward a hierarchy of mechanisms in CaMKII-mediated arrhythmia.Chasing cardiac physiology and pathology down the CaMKII cascade Protein phosphatase 2A regulatory subunit B56α limits phosphatase activity in the heart.Oxidant stress promotes disease by activating CaMKII.CaMKIIδ and cardiomyocyte Ca(2+) signalling new perspectives on splice variant targeting.ROS and intracellular ion channels.Vascular CaMKII: heart and brain in your arteries.Reversible redox modifications of ryanodine receptor ameliorate ventricular arrhythmias in the ischemic-reperfused heart.Muscarinic Stimulation Facilitates Sarcoplasmic Reticulum Ca Release by Modulating Ryanodine Receptor 2 Phosphorylation Through Protein Kinase G and Ca/Calmodulin-Dependent Protein Kinase II.Alternating membrane potential/calcium interplay underlies repetitive focal activity in a genetic model of calcium-dependent atrial arrhythmias.Mitochondrial-Mediated Oxidative Ca/Calmodulin-Dependent Kinase II Activation Induces Early Afterdepolarizations in Guinea Pig Cardiomyocytes: An In Silico Study

P2860

Q26852587-0689B668-215C-457B-8FB1-9AF90D17D4AB Q27302343-016C1CB3-4E5A-482D-9A30-4FB9CD7C8D72 Q27333918-1B158E8B-7836-455D-AFEF-61BBF6841482 Q33600515-429ED524-A29C-475E-98E7-2942F8F1DF34 Q33775402-3DF3D7E5-7C36-4984-8CA5-94983D26EBC8 Q35622415-938D859C-866A-4A38-A8F0-76AFD5C6C0B3 Q36376389-889FAADB-9691-498D-9C09-604878C6AF43 Q37358999-0C1E32E3-4103-458B-AAFE-E0BC23C126B6 Q38585093-3EAE4E49-0326-49EA-9460-FA4E0C6C33DE Q38781697-4D41076A-26EE-49ED-8458-43C7080CA555 Q38866040-5FC7EFFF-3483-4A67-B7F5-B8CF021CB46A Q42356974-49964DC3-C465-4DB9-8B61-D104E1622E08 Q42702471-78E2AF61-0EEE-47C3-88E1-16698FE588F3 Q52654918-610B0FEF-60D4-4DDD-B785-77D94281B361 Q58130055-F7224449-3F8A-42EF-AA71-E911A5CCF43F

P2860

Ryanodine receptor phosphorylation by oxidized CaMKII contributes to the cardiotoxic effects of cardiac glycosides.

http://www.wikidata.org/entity/Q37404177

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Ryanodine receptor phosphoryla ...... effects of cardiac glycosides.

@en

Ryanodine receptor phosphoryla ...... effects of cardiac glycosides.

@nl

type

label

Ryanodine receptor phosphoryla ...... effects of cardiac glycosides.

@en

Ryanodine receptor phosphoryla ...... effects of cardiac glycosides.

@nl

prefLabel

Ryanodine receptor phosphoryla ...... effects of cardiac glycosides.

@en

Ryanodine receptor phosphoryla ...... effects of cardiac glycosides.

@nl

P1433

Q37404177-9F2866DB-14A9-406A-B2A3-57B864203C82

P1476

Q37404177-DE73F5F7-3D57-4F63-B282-A76C1413C4B0

P2093

Q37404177-14315C09-ACEE-4C2C-8487-6ACBCBDD7D10

Q37404177-1555D62E-2414-4292-B447-DE5E82220C10

Q37404177-181F0F4C-B397-4536-A3F2-27F33BC96BF8

Q37404177-67372E5A-B136-42BA-8D3A-DB7779BB8739

Q37404177-6F05C889-F26E-4E4F-93F8-0B5A684D3A9D

Q37404177-76368265-3928-4DB5-BF1E-6BE0DC06E54E

Q37404177-7D647DC5-0618-43B0-82B1-1B59B646E7D4

Q37404177-85F96CED-C1A4-423A-A1A1-08D630B22DF5

Q37404177-9AD1D803-6A8B-4915-990B-DEDA91DA280F

Q37404177-B45105C8-18C4-4C1B-AD62-0864863DD72C

P2860

Q37404177-02792D59-E12B-4923-AA08-C8E791B42346

Q37404177-09393423-049A-40EB-B7AE-C549E3366EA9

Q37404177-0DF2C808-BBEF-41E2-A813-197EB6961374

Q37404177-1FCFE950-4AC2-4E90-8680-15C3D52514F0

Q37404177-3D5B92E0-0888-4B30-A059-9C607280627F

Q37404177-41483CDE-F07A-4EA8-B941-F593F6F7DC6A

Q37404177-41CB9E4A-82CD-4B02-9E51-18482208A4E4

Q37404177-445AD756-0E53-4D08-B7DB-D8CDB0331814

Q37404177-4E8BE71A-FD1E-469A-80C6-FEDC2C1E61F9

Q37404177-4FC5BDED-45FE-4581-A532-1ABBC56F6CE0

P304

Q37404177-570D342E-951F-4641-96AD-E43920FC9660

P31

Q37404177-898E9C59-04AE-4960-9749-0305BAD613A4

P356

Q37404177-A20CD4F1-7231-4A18-9DC2-5C9DEC3FA014

P433

Q37404177-DE959E80-4BB9-4EF1-A7ED-D531ED4110E0

P478

Q37404177-E956B64C-8204-4898-B812-F68ED14B8E27

P50

Q37404177-1BF182A8-8307-40A5-99CF-035427E7492A

P577

Q37404177-8B57FF0C-565B-4FB1-BDD9-FD5E8089DF09

P698

Q37404177-5031A153-A311-46D8-8142-0CEF434B7676

P921

Q37404177-B123B7C6-D446-463D-BBE4-65B8B2AB1658

P932

Q37404177-56F32A1A-D553-4242-9CEF-7008A5469456

P356

P1433

Cardiovascular Research

P1476

Ryanodine receptor phosphoryla ...... effects of cardiac glycosides.

@en

P2093

Bin Liu

http://www.w3.org/2001/XMLSchema#string

Brandon J Biesiadecki

http://www.w3.org/2001/XMLSchema#string

Chandan K Sen

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Brundage

http://www.w3.org/2001/XMLSchema#string

Florencia Velez-Cortes

http://www.w3.org/2001/XMLSchema#string

Honglan Wang

http://www.w3.org/2001/XMLSchema#string

Hsiang-Ting Ho

http://www.w3.org/2001/XMLSchema#string

Jedidiah S Snyder

http://www.w3.org/2001/XMLSchema#string

Mark E Anderson

http://www.w3.org/2001/XMLSchema#string

Mark T Ziolo

http://www.w3.org/2001/XMLSchema#string

P2860

The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure

The inotropic effect of cardioactive glycosides in ventricular myocytes requires Na+-Ca2+ exchanger function

Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production

Intramitochondrial signaling: interactions among mitoKATP, PKCepsilon, ROS, and MPT

Association of PI3K-Akt signaling pathway with digitalis-induced hypertrophy of cardiac myocytes

Arrhythmogenic adverse effects of cardiac glycosides are mediated by redox modification of ryanodine receptors

Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice.

Increased expression of catalase and superoxide dismutase 2 reduces cone cell death in retinitis pigmentosa.

Shortened Ca2+ signaling refractoriness underlies cellular arrhythmogenesis in a postinfarction model of sudden cardiac death.

Role of mitochondrial dysfunction in cardiac glycoside toxicity

P304

165-174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CVR/CVT233

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Xander H T Wehrens

P577

2013-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24104877

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation

P932

3868350

http://www.w3.org/2001/XMLSchema#string